Stay updated with breaking news from Trimm 2 trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bhagirathbhai R. Dholaria, MD, assistant professor of medicine in the Department of Hematology-Oncology at Vanderbilt University Medical Center, discussed findings from the phase 2 TRiMM-2 trial of talquetamab plus daratumumab in multiple myeloma. ....